Inspired by microbiology - driven by farmers needs -
ensuring safe and healthy food chains
Background
Pesticides are used to prevent diseases and to increase the food production capacity for centuries. The usage of pesticides is causing problems such as health effects, environmental pollution and food safety problems. According to World Health Organization 3,000,000 cases of pesticide poisoning and 220,000 deaths are reported in developing countries annually. The increasing need for food and the concern of the use of toxic chemical pesticides, force growers to look for new environmentally friendly products. However, there is a growing gap between what bio-solutions market can offer and what growers need.
Our mission is to protect food supplies without toxic residues. We develop novel biological active ingredients for a new generation of sustainable biocontrol products and biostimulants.
The company's office and microbiology laboratory are located at the Brightlands Chemelot Campus in Geleen, the Netherlands. The BioMosae team combines a broad technology background and R&D project experience (process technology, microbiology & biotechnology) with business development skills and a sharp innovation focus.
BioMosae is a discovery company for the development of active ingredients for biocontrols & biostimulants, based on microorganisms. The technology platform is based on proprietary bacterial strains and expertise how to optimize process conditions for these strains to produce biological active substances for application in agro industry.
BioMosae has established a bacterial library, containing numerous bacterial strains collected from all over Europe. To date BioMosae has identified a number of promising, novel active ingredients for various biofungicides and biostimulant products for both foliar- as well as seed application products.
The company evolved a streamlined approach for the discovery and identification of novel AI’s by chaining multidisciplinary and complementary methodologies. By combining fields of expertise from biotechnology, microbiology, proteomics and analytical chemistry, the approach was successfully employed for the discovery of novel bacterial AI with antifungal effects.
Currently, BioMosae B.V. is integrating this approach to intensify the development of additional PPP and consequently accelerating the market entrance of highly desired and innovative biological products. In addition, BioMosae B.V. aims to make this methodology available as a service for other agro-companies from similar fields of operation.
Technology
Our BM-1 strain produces enzymatic substance which has antifungal properties and growth enhancing effect
Our BM-1 strain can be immobilized, while keeping enough activity
Unique process conditions under which immobilized BM-1 strain can produce in a continuous system
2019
2020
2020
2021
2021
2022
2022
2023
2023
2024
2024
Patent applications filed
Awarded with Eurostars subsidy
Microbiology Lab Brightlands Chemelot Campus
Development of Canto-0 (2nd generation foliar biofungicide)
Successful greenhouse trials against Botrytis and Powdery Mildew
pre seed investment round
Participant in Startlife incubator program
Development of microbial AI seed treatment product
Product- and process freeze for Canto-0
Efficacy validation of Canto-0 in field trials by industry
Registration microbial AI for seed treatment
Partners
R&D Technology Partner
Materials Testing
Technical & Marketing Study
Funding
Funding
Patent
Funding
Development partner
Funding
Funding
Development partner
Development partner
Technology partner
Team
Alex Schmeets CEO
Worked for global engineering consultancy firms as well as for SME’s & start-ups in various senior Management- and BD roles, preferably at the intersection of technology, innovation and business development. Holding master degree in Mechanical Engineering from Technical University of Delft, The Netherlands.
Member of Advisory Commission of the Dutch Research council NWO for Take-Off program.
E. aschmeets@biomosae.com
T. +31 (0)6 81 399 128
Christian Schmitz CTO
Christian is researcher of Biomosae for product and process development.
PhD in Biotechnology. Obtained his PhD at Maastricht University, holds a MSc. in molecular biotechnology at the RWTH Aachen. He has more than 10 years of experience in recombinant protein production, bacterial cultivation, downstream processing and design-of-experiments.
Advisory board
-
Jan zuidam
Supervisory directorships and other positions held a.o.: Vice chairman managing board of Royal DSM, Chairman Technology VNO-NCW and Chairman VNCI.
-
marcel Wubbolts
CTO of Corbion, former CTO of DSM.
-
bob legro
Seed Technology Consultant, former MT member and R&D director of Incotec.
-
rob paffen
Financial Consultant, former controller of Liof participation fund.
-
marnix peferoen
VC Consultant, founder and former CEO of AgroSavfe/Biotalys.
